PDE2A and COVID-19: PDE2A's role in developing lung injury through disrupted endothelial membrane barriers likely reflects the upregulation of this gene in COVID‐19 patients and the increased risk for pulmonary complications such as acute respiratory distress syndrome (ARDS).